KRAS and cancer: p38 MAPK has been shown to inhibit oncogenic Hras (encode Hras, or Harvey Rat sarcoma virus or transforming protein p21) malignant transformation and ROS- activation of p38 signaling may trigger cell cycle arrest, suppress cell growth and division of cancer cells (Dolado et al. 2007).